Autologous progenitor expansion -T Cells Therapy（Shanghai Pudong Hospital）

N/A

Report date: 2024/11/27 20:00:40

Base Information

Drug NameAutologous progenitor expansion -T Cells Therapy（Shanghai Pudong Hospital）
Drug Alias NameAutologous Bi-dimensional Specific T Cells Therapy （Shanghai Pudong Hospital）Autologous progenitor expansion -T（Shanghai Pudong Hospital）Autologous Bi-dimensional Specific T Cells（Shanghai Pudong Hospital）
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsBrain metastasesGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Pudong Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Pudong Hospital
Active IndicationsN/A
Inactive IndicationsBrain metastasesGlioma

Other Information

ATC CodeN/A
Related LinksN/A